Liftstream is an executive search recruitment company in the life sciences sector
On January 10th 2013, BioMarin announced it had acquired the privately held US biotechnology company Zacharon Pharmaceuticals. Zacharon develops small molecules targeting pathways of glycan and glycolipid metabolism. BioMarin has purchased 100% of Zacahron’s shares with a $10m upfront payment combined with regular clinical, regulatory and commercial milestone payments. BioMarin operates in the Rare Disease space where it currently has 4 marketed products and now employs over 1000 personnel worldwide.